HbA1c und kardiovaskuläres Risiko bei übergewichtigen Patienten mit Typ-2-DiabetesCardiovascular risk and HbA1c levels in overweight patients with type 2 diabetes

被引：0
|
作者：
B. Nowotny
机构：
[1] Deutsches Diabetes-Zentrum an der Heinrich-Heine-Universität,Institut für Klinische Diabetologie
[2] Leibniz-Zentrum für Diabetesforschung,undefined
来源：
Der Diabetologe | 2012年 / 8卷 / 7期
关键词：
D O I：
10.1007/s11428-012-0988-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：581 / 582
页数：1
相关论文
共 50 条
  • [21] Cases of fulminant type 1 and type 2 diabetes mellitus whose HbA1c levels were unmeasurable due to increased labile HbA1c
    Kato, Shunsuke
    Otaka, Izumi
    Toyama, Hanako
    Kusumi, Ryota
    Takahashi, Kazuyuki
    Nara, Mitsuhiko
    Suganuma, Yumi
    Sato, Takehiro
    Morii, Tsukasa
    Fujita, Hiroki
    Waki, Hironori
    DIABETOLOGY INTERNATIONAL, 2022, 13 (04) : 698 - 703
  • [22] Cases of fulminant type 1 and type 2 diabetes mellitus whose HbA1c levels were unmeasurable due to increased labile HbA1c
    Shunsuke Kato
    Izumi Otaka
    Hanako Toyama
    Ryota Kusumi
    Kazuyuki Takahashi
    Mitsuhiko Nara
    Yumi Suganuma
    Takehiro Sato
    Tsukasa Morii
    Hiroki Fujita
    Hironori Waki
    Diabetology International, 2022, 13 : 698 - 703
  • [23] GLP-1-Mimetikum punktet auf allen EbenenRunter mit HbA1c, Gewicht und kardiovaskulärem Risiko
    Birgit Frohn
    MMW - Fortschritte der Medizin, 2011, 153 (16) : 56 - 56
  • [24] Seasonal variation in HbA1c in patients with Type 2 diabetes mellitus
    Carney, TA
    Guy, SP
    Helliwell, CD
    DIABETIC MEDICINE, 2000, 17 (07) : 554 - 555
  • [25] HbA1c levels among Tertiary Health Care patients with type 2 Diabetes
    Farrukh, Ambreen
    Shafique, Sadia
    Sajjad, Aiza
    Naeem, Saeed
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (03): : 1151 - 1153
  • [26] Effect of orlistat in patients with type 2 diabetes at differing baseline HbA1c levels
    De Fronzo, R
    Pi-Sunyer, FX
    DIABETES, 2002, 51 : A412 - A412
  • [27] Efficacy of orlistat in patients with type 2 diabetes with baseline HbA1c, levels ≥8%
    Davidson, JA
    Barnett, A
    DIABETES, 2002, 51 : A95 - A95
  • [28] Niedriger HbA1c bei Typ-II-Diabetes-Patienten schützt nicht vor schweren UnterzuckerungenErgebnisse der Diabetes and Aging StudyLower HbA1c in type 2 diabetes patients is no protection against severe hypoglycemiaResults of the Diabetes and Aging Study
    N. Hermanns
    Der Diabetologe, 2013, 9 (8): : 640 - 641
  • [29] The relationship of HbA1c and weight in the treatment of patients with type 2 diabetes
    Mathisen, AL
    Brockley, MR
    DIABETES, 2000, 49 : A117 - A117
  • [30] Hemoglobin A1c (HbA1c) and Subsequent Risk of Developing Type 2 Diabetes
    Selvin, Elizabeth
    Steffes, Michael W.
    Zhu, Hong
    Crain-Iceanu, Ciprian
    Wagenknecht, Lynne
    Pankow, James S.
    Brancati, Frederick L.
    Coresh, Josef
    DIABETES, 2009, 58 : A64 - A65
12345